Subject(s)
COVID-19 , Heart Failure , Expert Testimony , Fibrin Fibrinogen Degradation Products , Humans , Pandemics , Poland , SARS-CoV-2ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARSCoV2), a new coronavirus that induces acute respiratory failure among other conditions, is the cause of the rapidly spreading coronavirus disease 2019 (COVID19), affecting thousands of people around the world. The present expert opinion is a synthetic summary of the current knowledge on the various aspects of heart failure in patients with COVID19. The aim of the paper was to provide clinicians with necessary information useful in daily clinical practice.
ABSTRACT
New coronavirus (SARS-CoV-2, severe acute respiratory syndrome coronavirus) acute respiratory failure is the cause of the rapidly spreading coronavirus disease 2019 (COVID-19, coronavirus disease 2019), affecting thousands of people around the world. Due to the limited information on heart dysfunction in patients with COVID-19, a synthetic summary of current knowledge is needed to help clinicians who care for patients with cardiovascular disease, especially heart failure (HF) patients. We present the expert opinion of the Polish Cardiac Society - Working Group of Heart Failure (PCS - HF).